We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
HCP Tops Q3 FFO Estimates on NOI Growth, Misses on Revenues
Read MoreHide Full Article
HCP Inc. (HCP - Free Report) reported third-quarter 2018 funds from operations (FFO) as adjusted of 44 cents per share, beating the Zacks Consensus Estimate of 43 cents. Comparable FFO as adjusted in the prior-year quarter was 48 cents per share.
Results were supported by decent performance of the company’s life-science and medical-office segment.
This healthcare real estate investment trust (REIT) generated revenues of $456 million, narrowly missing the Zacks Consensus Estimate of $457.45 million. Nonetheless, the figure compares favorably with the year-ago number of $454 million.
Behind the Headlines
HCP witnessed 1.7% year-over-year rise in the three-month cash SPP net operating income (NOI). Though there was growth of 2.6% in life-science cash NOI, 1.6% increase in senior-housing triple-net segment, 2.3% rise in the medical office segment and 6.5% advancement in other non-reportable segments, the positives were partly offset by a 6.3% decrease in senior-housing operating portfolio (SHOP) cash NOI.
During the quarter under review, HCP completed the sale of 11 senior housing communities, totaling $76 million to third-party buyers.
Year to date, management of 35 senior-housing communities, owned by HCP, have been transitioned from Brookdale to other operators. The remaining four will likely be transitioned in 2018.
HCP had cash and cash equivalents of around $78.9 million as of Sep 30, 2018, significantly up from $55.3 million recorded at the end of 2017. Additionally, the company ended the third quarter with $1.4 billion of liquidity from a combination of cash and availability under its $2-billion credit facility.
Outlook
HCP reaffirmed its 2018 FFO as adjusted guidance at $1.79-$1.83 per share. The Zacks Consensus Estimate is pegged at $1.82.
Furthermore, the company reaffirmed the 2018 SPP cash NOI growth guidance of 0.25-1.75%.
Conclusion
Continuing with its portfolio-repositioning strategy, HCP disposed 11 senior housing communities during the Jul-Sep period. Further, in October, it closed on part of the previously-announced sale of 19 senior housing communities managed by Brookdale by selling 17 assets for $264 million. These efforts will enable the company to lower its exposure to Brookdale and optimize its portfolio.
Nevertheless, it recorded lower rental and related revenues, along with a decline in interest income, as compared to the prior-year quarter. Going forward, we identify rising interest rates and stiff competition as major hurdles for the company.
We now look forward to the earnings releases of Host Hotels & Resorts, Inc. (HST - Free Report) , Equinix, Inc. (EQIX - Free Report) and Outfront Media Inc. (OUT - Free Report) . While Host Hotels is scheduled to report its quarterly numbers on Nov 2, Equinix and Outfront are slated to report their third-quarter earnings on Nov 1 and Nov 5, respectively.
Note: Anything related to earnings presented in this write-up represent funds from operations (FFO) — a widely used metric to gauge the performance of REITs.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
Image: Bigstock
HCP Tops Q3 FFO Estimates on NOI Growth, Misses on Revenues
HCP Inc. (HCP - Free Report) reported third-quarter 2018 funds from operations (FFO) as adjusted of 44 cents per share, beating the Zacks Consensus Estimate of 43 cents. Comparable FFO as adjusted in the prior-year quarter was 48 cents per share.
Results were supported by decent performance of the company’s life-science and medical-office segment.
This healthcare real estate investment trust (REIT) generated revenues of $456 million, narrowly missing the Zacks Consensus Estimate of $457.45 million. Nonetheless, the figure compares favorably with the year-ago number of $454 million.
Behind the Headlines
HCP witnessed 1.7% year-over-year rise in the three-month cash SPP net operating income (NOI). Though there was growth of 2.6% in life-science cash NOI, 1.6% increase in senior-housing triple-net segment, 2.3% rise in the medical office segment and 6.5% advancement in other non-reportable segments, the positives were partly offset by a 6.3% decrease in senior-housing operating portfolio (SHOP) cash NOI.
During the quarter under review, HCP completed the sale of 11 senior housing communities, totaling $76 million to third-party buyers.
Year to date, management of 35 senior-housing communities, owned by HCP, have been transitioned from Brookdale to other operators. The remaining four will likely be transitioned in 2018.
HCP had cash and cash equivalents of around $78.9 million as of Sep 30, 2018, significantly up from $55.3 million recorded at the end of 2017. Additionally, the company ended the third quarter with $1.4 billion of liquidity from a combination of cash and availability under its $2-billion credit facility.
Outlook
HCP reaffirmed its 2018 FFO as adjusted guidance at $1.79-$1.83 per share. The Zacks Consensus Estimate is pegged at $1.82.
Furthermore, the company reaffirmed the 2018 SPP cash NOI growth guidance of 0.25-1.75%.
Conclusion
Continuing with its portfolio-repositioning strategy, HCP disposed 11 senior housing communities during the Jul-Sep period. Further, in October, it closed on part of the previously-announced sale of 19 senior housing communities managed by Brookdale by selling 17 assets for $264 million. These efforts will enable the company to lower its exposure to Brookdale and optimize its portfolio.
Nevertheless, it recorded lower rental and related revenues, along with a decline in interest income, as compared to the prior-year quarter. Going forward, we identify rising interest rates and stiff competition as major hurdles for the company.
HCP, Inc. Price, Consensus and EPS Surprise
HCP, Inc. Price, Consensus and EPS Surprise | HCP, Inc. Quote
HCP currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
We now look forward to the earnings releases of Host Hotels & Resorts, Inc. (HST - Free Report) , Equinix, Inc. (EQIX - Free Report) and Outfront Media Inc. (OUT - Free Report) . While Host Hotels is scheduled to report its quarterly numbers on Nov 2, Equinix and Outfront are slated to report their third-quarter earnings on Nov 1 and Nov 5, respectively.
Note: Anything related to earnings presented in this write-up represent funds from operations (FFO) — a widely used metric to gauge the performance of REITs.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
See them today for free >>